Here, we use RT-QuIC assays to directly measure 3R/4R tau, 4R tau, and α-syn seeds in brain tissue from a spectrum of neurodegenerative diseases inclusive of AD, synucleinopathies, 4R tauopathies, and control cases. This evidence concerns the gene MAPT and tauopathy.